Fig. 1 · Structure
Documents & Downloads
Limazocic
Hepatoprotective Agent
Limazocic is an orally active hepatoprotective agent that targets liver injury mechanisms. This compound inhibits increases in serum transaminase, alkaline phosphatase activity, and hepatic lipid levels induced by carbon tetrachloride (CCl4). Additionally, Limazocic reduces the extent of hepatic necrosis, fibrosis, and steatosis. Its properties make Limazocic a valuable tool for research on chronic liver injuries and associated pathologies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 128620-82-6 |
| Applications | Hepatoprotective Agent |
| Formula | C8H13NO3S2 |
| Molecular Weight | 235.32 |
| Synonyms | SA 3443 |
| SMILES | OC([C@H]1NC(C(C)(CSSC1)C)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.